Rasio utang jangka dawa marang modal MeiraGTx Corp (MGTX)

The daily price chart for MeiraGTx Holdings plc (MGTX) allows for an assessment of the company's stability, as it has established a reliable biomaterial delivery system through its hubs, ensuring high margins. The current figure is 0.54. The business specializes in therapies for rare pathologies, utilizing in-house vector production capabilities to accelerate drug time-to-market. The presence of certified manufacturing plants minimizes development risks and attracts strategic partners.

This indicator assesses the issuer's financial stability by determining the proportion of debt with a maturity exceeding one year relative to the company's equity. By analyzing the current long-term debt-to-equity ratio, an investor can discern the level of leverage required by MeiraGTx Holdings plc (MGTX) to finance the capital-intensive implementation of automated GMP platforms and robotic viral vector synthesis systems.